Efficacy and sustainability of a footcare programme in preventing acute attacks of adenolymphangitis in Brugian filariasis.
Identifieur interne : 009467 ( Main/Exploration ); précédent : 009466; suivant : 009468Efficacy and sustainability of a footcare programme in preventing acute attacks of adenolymphangitis in Brugian filariasis.
Auteurs : T K Suma [Inde] ; R K Shenoy ; V. KumaraswamiSource :
- Tropical medicine & international health : TM & IH [ 1360-2276 ] ; 2002.
Descripteurs français
- KwdFr :
- Acide salicylique (administration et posologie), Administration par voie cutanée, Adolescent, Adulte, Adulte d'âge moyen, Animaux, Brugia, Comportement en matière de santé, Femelle, Filariose lymphatique (), Humains, Inde (épidémiologie), Lymphangite (), Maladie aigüe, Maladies du pied (), Mâle, Onguents, Promotion de la santé, Services de médecine préventive, Sujet âgé, Éducation pour la santé, Études de suivi, Évaluation de programme.
- MESH :
- administration et posologie : Acide salicylique.
- épidémiologie : Inde.
- Administration par voie cutanée, Adolescent, Adulte, Adulte d'âge moyen, Animaux, Brugia, Comportement en matière de santé, Femelle, Filariose lymphatique, Humains, Lymphangite, Maladie aigüe, Maladies du pied, Mâle, Onguents, Promotion de la santé, Services de médecine préventive, Sujet âgé, Éducation pour la santé, Études de suivi, Évaluation de programme.
- Wicri :
- geographic : Inde.
English descriptors
- KwdEn :
- Acute Disease, Administration, Cutaneous, Adolescent, Adult, Aged, Animals, Brugia, Elephantiasis, Filarial (complications), Elephantiasis, Filarial (prevention & control), Female, Follow-Up Studies, Foot Diseases (complications), Foot Diseases (prevention & control), Health Behavior, Health Education, Health Promotion, Humans, India (epidemiology), Lymphangitis (complications), Lymphangitis (prevention & control), Male, Middle Aged, Ointments, Preventive Health Services, Program Evaluation, Salicylic Acid (administration & dosage).
- MESH :
- chemical , administration & dosage : Salicylic Acid.
- chemical : Ointments.
- geographic , epidemiology : India.
- complications : Elephantiasis, Filarial, Foot Diseases, Lymphangitis.
- prevention & control : Elephantiasis, Filarial, Foot Diseases, Lymphangitis.
- Acute Disease, Administration, Cutaneous, Adolescent, Adult, Aged, Animals, Brugia, Female, Follow-Up Studies, Health Behavior, Health Education, Health Promotion, Humans, Male, Middle Aged, Preventive Health Services, Program Evaluation.
Abstract
Lymphatic filariasis is associated with considerable disability related to the intensity and frequency of acute adenolymphangitis (ADL) attacks. The global programme for elimination of lymphatic filariasis emphasizes the need to combine transmission control with alleviation of disability. Footcare aimed at the prevention of secondary bacterial infections is the mainstay of disability alleviation programmes. We evaluated the efficacy and sustainability of an unsupervised, personal footcare programme by examining and interviewing 127 patients who had previously participated in a trial that assessed the efficacy of diethylcarbamazine, penicillin and footcare in the prevention of ADL. During the trial period these patients had been educated in footcare and were supervised. During the unsupervised period, which lasted 1 year or longer, 47 patients developed no ADL, and ADL occurred less frequently in 72.5%. Most patients were practising footcare as originally advised, unsupervised and without cost, which proves that such a programme is sustainable and effective.
PubMed: 12225507
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: 004482
- to stream PubMed, to step Curation: 004482
- to stream PubMed, to step Checkpoint: 004482
- to stream Ncbi, to step Merge: 000A96
- to stream Ncbi, to step Curation: 000A96
- to stream Ncbi, to step Checkpoint: 000A96
- to stream Main, to step Merge: 009832
- to stream Main, to step Curation: 009467
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Efficacy and sustainability of a footcare programme in preventing acute attacks of adenolymphangitis in Brugian filariasis.</title><author><name sortKey="Suma, T K" sort="Suma, T K" uniqKey="Suma T" first="T K" last="Suma">T K Suma</name><affiliation wicri:level="1"><nlm:affiliation>Filariasis Chemotherapy Unit, T.D. Medical College Hospital, Alappuzha 688011, Kerala, India.</nlm:affiliation><country xml:lang="fr">Inde</country><wicri:regionArea>Filariasis Chemotherapy Unit, T.D. Medical College Hospital, Alappuzha 688011, Kerala</wicri:regionArea><wicri:noRegion>Kerala</wicri:noRegion></affiliation></author><author><name sortKey="Shenoy, R K" sort="Shenoy, R K" uniqKey="Shenoy R" first="R K" last="Shenoy">R K Shenoy</name></author><author><name sortKey="Kumaraswami, V" sort="Kumaraswami, V" uniqKey="Kumaraswami V" first="V" last="Kumaraswami">V. Kumaraswami</name></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2002">2002</date><idno type="RBID">pubmed:12225507</idno><idno type="pmid">12225507</idno><idno type="wicri:Area/PubMed/Corpus">004482</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">004482</idno><idno type="wicri:Area/PubMed/Curation">004482</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">004482</idno><idno type="wicri:Area/PubMed/Checkpoint">004482</idno><idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">004482</idno><idno type="wicri:Area/Ncbi/Merge">000A96</idno><idno type="wicri:Area/Ncbi/Curation">000A96</idno><idno type="wicri:Area/Ncbi/Checkpoint">000A96</idno><idno type="wicri:doubleKey">1360-2276:2002:Suma T:efficacy:and:sustainability</idno><idno type="wicri:Area/Main/Merge">009832</idno><idno type="wicri:Area/Main/Curation">009467</idno><idno type="wicri:Area/Main/Exploration">009467</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Efficacy and sustainability of a footcare programme in preventing acute attacks of adenolymphangitis in Brugian filariasis.</title><author><name sortKey="Suma, T K" sort="Suma, T K" uniqKey="Suma T" first="T K" last="Suma">T K Suma</name><affiliation wicri:level="1"><nlm:affiliation>Filariasis Chemotherapy Unit, T.D. Medical College Hospital, Alappuzha 688011, Kerala, India.</nlm:affiliation><country xml:lang="fr">Inde</country><wicri:regionArea>Filariasis Chemotherapy Unit, T.D. Medical College Hospital, Alappuzha 688011, Kerala</wicri:regionArea><wicri:noRegion>Kerala</wicri:noRegion></affiliation></author><author><name sortKey="Shenoy, R K" sort="Shenoy, R K" uniqKey="Shenoy R" first="R K" last="Shenoy">R K Shenoy</name></author><author><name sortKey="Kumaraswami, V" sort="Kumaraswami, V" uniqKey="Kumaraswami V" first="V" last="Kumaraswami">V. Kumaraswami</name></author></analytic><series><title level="j">Tropical medicine & international health : TM & IH</title><idno type="ISSN">1360-2276</idno><imprint><date when="2002" type="published">2002</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Acute Disease</term><term>Administration, Cutaneous</term><term>Adolescent</term><term>Adult</term><term>Aged</term><term>Animals</term><term>Brugia</term><term>Elephantiasis, Filarial (complications)</term><term>Elephantiasis, Filarial (prevention & control)</term><term>Female</term><term>Follow-Up Studies</term><term>Foot Diseases (complications)</term><term>Foot Diseases (prevention & control)</term><term>Health Behavior</term><term>Health Education</term><term>Health Promotion</term><term>Humans</term><term>India (epidemiology)</term><term>Lymphangitis (complications)</term><term>Lymphangitis (prevention & control)</term><term>Male</term><term>Middle Aged</term><term>Ointments</term><term>Preventive Health Services</term><term>Program Evaluation</term><term>Salicylic Acid (administration & dosage)</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Acide salicylique (administration et posologie)</term><term>Administration par voie cutanée</term><term>Adolescent</term><term>Adulte</term><term>Adulte d'âge moyen</term><term>Animaux</term><term>Brugia</term><term>Comportement en matière de santé</term><term>Femelle</term><term>Filariose lymphatique ()</term><term>Humains</term><term>Inde (épidémiologie)</term><term>Lymphangite ()</term><term>Maladie aigüe</term><term>Maladies du pied ()</term><term>Mâle</term><term>Onguents</term><term>Promotion de la santé</term><term>Services de médecine préventive</term><term>Sujet âgé</term><term>Éducation pour la santé</term><term>Études de suivi</term><term>Évaluation de programme</term></keywords><keywords scheme="MESH" type="chemical" qualifier="administration & dosage" xml:lang="en"><term>Salicylic Acid</term></keywords><keywords scheme="MESH" type="chemical" xml:lang="en"><term>Ointments</term></keywords><keywords scheme="MESH" type="geographic" qualifier="epidemiology" xml:lang="en"><term>India</term></keywords><keywords scheme="MESH" qualifier="administration et posologie" xml:lang="fr"><term>Acide salicylique</term></keywords><keywords scheme="MESH" qualifier="complications" xml:lang="en"><term>Elephantiasis, Filarial</term><term>Foot Diseases</term><term>Lymphangitis</term></keywords><keywords scheme="MESH" qualifier="prevention & control" xml:lang="en"><term>Elephantiasis, Filarial</term><term>Foot Diseases</term><term>Lymphangitis</term></keywords><keywords scheme="MESH" qualifier="épidémiologie" xml:lang="fr"><term>Inde</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Acute Disease</term><term>Administration, Cutaneous</term><term>Adolescent</term><term>Adult</term><term>Aged</term><term>Animals</term><term>Brugia</term><term>Female</term><term>Follow-Up Studies</term><term>Health Behavior</term><term>Health Education</term><term>Health Promotion</term><term>Humans</term><term>Male</term><term>Middle Aged</term><term>Preventive Health Services</term><term>Program Evaluation</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Administration par voie cutanée</term><term>Adolescent</term><term>Adulte</term><term>Adulte d'âge moyen</term><term>Animaux</term><term>Brugia</term><term>Comportement en matière de santé</term><term>Femelle</term><term>Filariose lymphatique</term><term>Humains</term><term>Lymphangite</term><term>Maladie aigüe</term><term>Maladies du pied</term><term>Mâle</term><term>Onguents</term><term>Promotion de la santé</term><term>Services de médecine préventive</term><term>Sujet âgé</term><term>Éducation pour la santé</term><term>Études de suivi</term><term>Évaluation de programme</term></keywords><keywords scheme="Wicri" type="geographic" xml:lang="fr"><term>Inde</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Lymphatic filariasis is associated with considerable disability related to the intensity and frequency of acute adenolymphangitis (ADL) attacks. The global programme for elimination of lymphatic filariasis emphasizes the need to combine transmission control with alleviation of disability. Footcare aimed at the prevention of secondary bacterial infections is the mainstay of disability alleviation programmes. We evaluated the efficacy and sustainability of an unsupervised, personal footcare programme by examining and interviewing 127 patients who had previously participated in a trial that assessed the efficacy of diethylcarbamazine, penicillin and footcare in the prevention of ADL. During the trial period these patients had been educated in footcare and were supervised. During the unsupervised period, which lasted 1 year or longer, 47 patients developed no ADL, and ADL occurred less frequently in 72.5%. Most patients were practising footcare as originally advised, unsupervised and without cost, which proves that such a programme is sustainable and effective.</div></front></TEI><affiliations><list><country><li>Inde</li></country></list><tree><noCountry><name sortKey="Kumaraswami, V" sort="Kumaraswami, V" uniqKey="Kumaraswami V" first="V" last="Kumaraswami">V. Kumaraswami</name><name sortKey="Shenoy, R K" sort="Shenoy, R K" uniqKey="Shenoy R" first="R K" last="Shenoy">R K Shenoy</name></noCountry><country name="Inde"><noRegion><name sortKey="Suma, T K" sort="Suma, T K" uniqKey="Suma T" first="T K" last="Suma">T K Suma</name></noRegion></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 009467 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 009467 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= LymphedemaV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= pubmed:12225507
|texte= Efficacy and sustainability of a footcare programme in preventing acute attacks of adenolymphangitis in Brugian filariasis.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:12225507" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \
| NlmPubMed2Wicri -a LymphedemaV1
| This area was generated with Dilib version V0.6.31. |  |